Search Results - "Lilenbaum, R.C."

Final Results of a Phase I Prospective Trial Evaluating the Combination of Stereotactic Body Radiation Therapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) or Melanoma by Campbell, A.M., Herbst, R.S., Gettinger, S.N., Goldberg, S.B., Kluger, H.M., Chiang, A.C., Lilenbaum, R.C., Schalper, K.A., Sowell, R., Kaech, S., Decker, R.H.

Get full text

Interim safety results from the phase 2 ABOUND.PS2 study evaluating nab-paclitaxel (nab-P) + carboplatin (C) followed by nab-P monotherapy in patients (pts) with NSCLC and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2 by Gajra, A., Ali, H., Amiri, K.I., Karim, N. Abdel, Matrana, M.R., Mulford, D., Ong, T.J., Sanford, A., Santos, E., Socinski, M., Spigel, D.R., Lilenbaum, R.C.

Get full text

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer by Lilenbaum, R. C., Chen, C.-S., Chidiac, T., Schwarzenberger, P. O., Thant, M., Versola, M., Lane, S. R.

“…Background: The purpose of this study was to compare quality of life and overall toxicity in patients with advanced non-small-cell lung cancer (NSCLC) treated…”
Get full text

Issues at the cutting edge in stage III non-small-cell lung cancer by Green, M R, Lilenbaum, R C

Get more information